Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Pharmaceutical Glass Ampoules Market size was over USD 4.2 billion in 2024 and is anticipated to cross USD 10.25 billion by 2037, growing at more than 7.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of pharmaceutical glass ampoules is estimated at USD 4.45 billion.
The growth of the market can be attributed to the rapid growth of pharmaceutical industry around the globe, stringent government regulations to improve the quality of manufactured drugs, and the rising preference for injection based treatments, such as that of diabetes. Apart from these, the emergence of glass as a cost-effective, safe and efficient packaging solution is also expected to drive market growth in the near future. Furthermore, growing demand for COVID-19 vaccination across the world is evaluated to offer ample opportunities to the pharmaceutical glass ampoules market in 2021 and the following years. For instance, till date India has witnessed the largest demand for COVID-19 vaccines in the world. The country has secured more than 2 billion vaccine doses in total.
Pharmaceutical Glass Ampoules Sector: Growth Drivers and Challenges
Growth Drivers
- Rapid Growth of Pharmaceutical Industry Worldwide
- Growing Preference for Injection Based Treatment Globally
Challenges
- Concerns Regarding Glass Delamination while Packaging Drugs
Pharmaceutical Glass Ampoules Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.1% |
|
Base Year Market Size (2024) |
USD 4.2 billion |
|
Forecast Year Market Size (2037) |
USD 10.25 billion |
|
Regional Scope |
|
Pharmaceutical Glass Ampoules Segmentation
The pharmaceutical glass ampoules market is segmented by type into open funnel, closed funnel, straight stem, and others, out of which, the straight stem segment is anticipated to hold the largest share in the market on account of deployment of advanced technologies among drug packaging manufacturers and growing emphasis on improving product quality. In addition, on the basis of drug type, the segment for generic drugs is projected to grab the largest market share owing to the increasing geriatric population, growing number of incidences of chronic diseases and escalating expiration of drug patents. Moreover, the biologic segment is assessed to grow with the highest growth rate over the forecast period on the ability of biologics to effectively treat several types of autoimmune diseases and cancer, and rising usage of glass packaging for these drugs.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Capacity |
|
|
By Drug Type |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportPharmaceutical Glass Ampoules Industry - Regional Synopsis
On the basis of geographical analysis, the pharmaceutical glass ampoules market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. North America industry is poised to account for largest revenue share by 2037, led by increasing demand for glass ampoules and the rising spending of the pharmaceutical industry in the region. Additionally, Europe is expected to be the second largest shareholder in the market in the coming years, which can be credited to the growing R&D activities in the medical sector and presence of strong market players in the region. However, the pharmaceutical glass ampoules market in Asia Pacific is evaluated to grow with the highest CAGR during the forecast period ascribing to the increasing health consciousness amongst people, growing disposable income, and rise in the prevalence of chronic disorders in the region. In India, more than 2 million people suffered from cancer in 2018. Out of these, approximately 785,000 people succumbed to the disease in that year.
Companies Dominating the Pharmaceutical Glass Ampoules Landscape
- Corning Incorporated
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- SCHOTT AG
- PIRAMIDA d.o.o.
- Gerresheimer AG
- NIPRO Corporation
- Stevanato Group
- SGD S.A.
- Shandong Medicinal Glass Co., Ltd.
- Ardagh Group S.A.
Author Credits: Radhika Pawar
- Report ID: 3059
- Published Date: Dec 24, 2024
- Report Format: PDF, PPT
